Status:
COMPLETED
The Effect of SHOTBLOCKER
Lead Sponsor:
Istanbul Medeniyet University
Conditions:
Shotblocker
Injection Pain Prevention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study was conducted as a randomized controlled experimental cross over study to examine the effect of injection pain, anxiety and comfort level with the use of Shotblocker in geriatric patients u...
Detailed Description
This study was conducted as a randomized controlled experimental cross over study to examine the effect of injection pain, anxiety and comfort level with the use of Shotblocker in geriatric patients u...
Eligibility Criteria
Inclusion
- Voluntary participants in the study, Over 65 years of age, Cognitive ability to answer the questions, Body Mass Index (BMI) 18.5- 29.9 kg / m2, No communication problems, Subcutaneous injection in the treatment, No bleeding coagulation disorder, Platelet, INR and APTT values within normal limits, No scar tissue, incision or infection findings in the injection area, No history of allergy
Exclusion
- Patients with amputation in the right/left arm area to be studied, Patients with any scar tissue, incision, lipodystrophy or signs of infection in the injection area in the arm area, Patients receiving hemodialysis treatment and having a dialysis catheter, Patients who underwent mastectomy surgery and should not undergo any application/treatment on the arm on the operated side were excluded from the study.
Key Trial Info
Start Date :
December 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06956066
Start Date
December 21 2023
End Date
December 21 2024
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul
Istanbul, Kartal, Turkey (Türkiye), 34862